Genentech (NYSE: DNA) : Roche announced on July 21 the offer to buy the balance of 44% of DNA it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE